Vaccination against pneumococcus in West Africa: Perspectives and prospects

International Journal of General Medicine

Volumn 6, Issue , 2013, Pages 757-764

  Donkor, Eric S ^a   Dayie, Nicholas T K D ^a,b   Badoe, Ebenezer V ^a  

^a UNIVERSITY OF GHANA   (Ghana)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Conjugate vaccines; Pneumococcal disease; Pneumococcus; PVC10; PVC13; Serotype; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; BURKINA FASO; GAMBIA; GHANA; HUMAN; INCIDENCE; MALI; MORTALITY; NIGERIA; PNEUMOCOCCAL INFECTION; SENEGAL; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW; VACCINATION;

EID: 84884222230     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S45842     Document Type: Article

References (36)

1. Pneumococcal vaccines: World Health Organization position paper. Can Commun Dis Rep. 1999;25(17):150-151. English and French.
2. O'Brien KL, Wolfson LJ, Watt JP, et al; Hib and Pneumococcal Global Burden of Disease Study Team. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374(9693):893-902.
3. Van Bambeke F, Reinert RR, Appelbaum PC, Tulkens PM, Peetermans WE. Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options. Drugs. 2007;67(16):2355-2382.
4. Selman S, Hayes D, Perin LA, Hayes WS. Pneumococcal conjugate vaccine for young children. Manag Care. 2000;9(9):49-52, 54, 56-57.
5. Centers for Disease Control and Prevention (CDC). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease - United States, 1998-2003. MMWR Morb Mortal Wkly Rep. 2005;5(36)4:893-897.
6. Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly Epidemiol Rec. 2007;82(12):93-104.
7. Greenwood B. Pneumococcal meningitis epidemics in Africa. Clin Infect Dis. 2006;43(6):701-703.
8. Antonio M, Hakeem I, Awine T, et al. Seasonality and outbreak of a predominant Streptococcus pneumoniae serotype 1 clone from The Gambia: expansion of ST217 hypervirulent clonal complex in West Africa. BMC Microbiol. 2008;8:198.
9. Yaro S, Lourd M, Traoré Y, et al. Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso. Clin Infect Dis. 2006;43(6):693-700.
10. Leimkugel J, Adams Forgor A, Gagneux S, et al. An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis. 2005;192(2):192-199.
11. Obaro S, Adegbola R. The pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol. 2002;51(2):98-104.
12. Hill PC, Akisanya A, Sankareh K, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers. Clin Infect Dis. 2006;43(6):673-679.
13. Adetifa IM, Antonio M, Okoromah CA, et al. Pre-vaccination nasopharyngeal pneumococcal carriage in a Nigerian population: epidemiology and population biology. PLoS One. 2012;7(1):e30548.
14. Hill PC, Cheung YB, Akisanya A, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study. Clin Infect Dis. 2008;46(6):807-814.
15. GAVI Alliance. Pneumococcal vaccine support [web page on the Internet]. Geneva: GAVI Alliance; nd. Available from: http://www.gavialliance.org/support/nvs/pneumococcal/. Accessed on March 20, 2013.
16. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
17. Johnson HL, Deloria-Knoll M, Levine OS, et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010;7(10). pii: e1000348.
18. Mudhune S, Wamae M; Network Surveillance for Pneumococcal Disease in the East African Region. Report on invasive disease and meningitis due to Haemophilus influenzae and Streptococcus pneumonia from the Network for Surveillance of Pneumococcal Disease in the East African Region. Clin Infect Dis. 2009;48 Suppl 2:S147-S152.
19. Kisakye A, Makumbi I, Nansera D, et al. Surveillance for Streptococcus pneumoniae meningitis in children aged,5 years: implications for immunization in Uganda. Clin Infect Dis. 2009;48 Suppl 2: S153-S161.
20. Hoile E. Pneumococcal serotypes in Europe: results of a surveillance report for 1999. Euro Surveill. 2002;6(31):pii 1908.
21. Obaro S. Differences in invasive pneumococcal serotypes. Lancet. 2001;357(9270):1800-1801.
22. GAVI's PneumoADIP. GAVI's Pneumo ADIP: Surveillance and Research Report. Baltimore, MD: GAVI's PneumoADIP; 2007. Available from: http://s3.amazonaws.com/zanran_storage/pneumoadip.idfive.com/ContentPages/2466704508.pdf. Accessed July 8, 2013.
23. Vila-Córcoles A. Advances in pneumococcal vaccines: what are the advantages for the elderly? Drugs Aging. 2007;24(10):791-800.
24. Mathew JL. Pneumococcal vaccination in developing countries: where does science end and commerce begin? Vaccine. 2009;27(32): 4247-4251.
25. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007;297(16):1784-1792.
26. Hanage WP. Serotype-specific problems associated with pneumococcal conjugate vaccination. Future Microbiol. 2008;3(1):23-30.
27. Traore Y, Tameklo TA, Njanpop-Lafourcade BM, et al. Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo. Clin Infect Dis. 2009;48 Suppl 2: S181-S189.
28. Cadoz M, Denis F, Mar ID. An epidemiological study of purulent meningitis cases admitted to hospital in Dakar, 1970-1979. Bull World Health Organ. 1981;59(4):575-584. French.
29. Leimkugel J, Adams Forgor A, Gagneux S, et al. An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis. 2005;192(2):192-199.
30. Enwere G, Biney E, Cheung Y, et al. Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The Gambia. Pediatr Infect Dis J. 2006;25(8):700-705.
31. Onyemelukwe GC, Greenwood BM. Pneumococcal serotypes, epidemiological factors and vaccine strategy in Nigerian patients. J Infect. 1983;5(2):157-163.
32. Campbell JD, Kotloff KL, Sow SO, et al. Invasive pneumococcal infections among hospitalized children in Bamako, Mali. Pediatr Infect Dis J. 2004;23(7):642-649.
33. Adegbola RA, Hill PC, Secka O, et al. Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003. Trop Med Int Health. 2006;11(7):1128-1135.
34. Antonio M, Hakeem I, Awine T, et al. Seasonality and outbreak of a predominant Streptococcus pneumoniae serotype 1 clone from The Gambia: expansion of ST217 hypervirulent clonal complex in West Africa. BMC Microbiol. 2008;8:198.
35. Yaro S, Lourd M, Traoré Y, et al. Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso. Clin Infect Dis. 2006;43(6):693-700.
36. Antonio M, Dada-Adegbola H, Biney E, et al. Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine. BMC Infect Dis. 2008;8:81.